Literature DB >> 5348494

In Canada: a trial of chemoprophylaxis in inactive tuberculosis.

S Grzybowski, M J Ashley, N E McKinnon, G Pinkus, R Philipps, A Brown.   

Abstract

One thousand five hundred and thirty-six patients with inactive tuberculosis were given a course of preventive treatment consisting of either INH alone or INH and PAS while 840 similar patients served as a control group. Discontinuation of the treatment was frequent and was usually caused by development of complaints which the patients ascribed to the drugs they were taking.The annual reactivation rate among controls was 4.9 per 1000. During the period of taking drugs the treated group suffered a reactivation rate of 0.7 per 1000 and those who had taken the medication for at least six months suffered a subsequent annual reactivation rate of 1.3 per 1000. The rate for those who discontinued treatment in the first six months was 5.1 per 1000. There were no reactivations in patients who took INH and PAS for over six months. Bacilli from two of the patients with reactivations who were treated for a prolonged period with INH alone showed resistance to this drug.Chemoprophylaxis of inactive cases is a potent weapon in tuberculosis control; however, it requires thorough motivation and supervision.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5348494      PMCID: PMC1946284     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  2 in total

1.  THE EFFICIENCY OF POST-SANATORIUM MANAGEMENT OF TUBERCULOSIS. A STUDY OF ONE THOUSAND TUBERCULOUS PATIENTS DISCHARGED FROM SANATORIA IN ONTARIO.

Authors:  E A ALLEN; M STEWART; P JENEY
Journal:  Can J Public Health       Date:  1964-08

2.  EFFECT OF ISONIAZID UPON THE REACTIVATION OF INACTIVE TUBERCULOSIS; FINAL REPORT.

Authors:  J KATZ; S KUNOFSKY; V DAMIJONAITIS; A LAFLEUR; T CARON
Journal:  Am Rev Respir Dis       Date:  1965-03
  2 in total
  1 in total

Review 1.  Close contact investigation of TB in high-burden, low- and middle-income countries.

Authors:  Y K Pang
Journal:  Malays Fam Physician       Date:  2014-08-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.